Author

Brian Jones

Sangamo BioSciences (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:Arabidopsis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

Alex Michael WardiD· 1 shared Alicia GoodwiniD· 1 shared Amy M. PooleriD· 1 shared Anthony Chikere· 1 shared Bryan ZeitleriD· 1 shared Dianna Baldwin VidalesiD· 1 shared Jason A. EshlemaniD· 1 shared Jason D. FontenotiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alex Michael WardORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Polymeric Nanoparticle System for the Delivery of CRISPR/Cas9 Components into Arabidopsis Pollen

Qinqin Yang, Liam D. Adair, Brian Jones, Markus Müllner

This paper develops a polymeric nanoparticle system to deliver CRISPR/Cas9 components into Arabidopsis pollen, enabling DNA-free genome editing without tissue culture.

bioRxiv · Jun 19, 2026 · PreprintPlant Biology

Potent and selective repression of SCN9A by engineered zinc finger repressors for the treatment of neuropathic pain

Mohammad Samie, Toufan Parman, Mihika Jalan, Jisoo Lee, Patrick J. Dunn, Jason A. Eshleman, Dianna Baldwin Vidales, Josh Holter, Brian Jones, Yonghua Pan, Marina Falaleeva, Sarah J. Hinkley, Alicia Goodwin, Tammy Chen, Sumita Bhardwaj, , Amy M. Pooler

This study demonstrates the use of engineered zinc finger repressors delivered via AAV to reduce SCN9A expression in preclinical models, showing efficacy in reducing neuropathic pain.

bioRxiv · Sep 6, 2024 · PreprintNeuroscience